Target intelligence / Profile preview

Autoinducer-2-binding periplasmic protein LsrB (LsrB) (LsrB)

Target
LsrB
Molecular classification
Periplasmic binding protein, ABC transporter substrate-binding protein, Receptor
01

Overview

Autoinducer-2-binding periplasmic protein LsrB (LsrB) is a critical component of the quorum-sensing apparatus in various Gram-negative bacteria, including Escherichia coli and Salmonella enterica (UniProt P0AEU3). It functions as the primary periplasmic receptor for autoinducer-2 (AI-2), a signaling molecule often termed the universal language for interspecies bacterial communication (Xavier & Bassler, 2005). LsrB specifically binds the (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF) form of AI-2 and facilitates its transport into the cytoplasm via the Lsr ABC transporter system (Miller et al., 2004). Once internalized, AI-2 is processed to regulate gene expression related to biofilm formation, virulence, and metabolic adaptation, making LsrB a focal point for bacterial group behavior (Ha et al., 2013). As a therapeutic target, LsrB is being explored for the development of anti-virulence agents that aim to disrupt bacterial coordination without killing the cells, thereby minimizing the selective pressure for antibiotic resistance (Galloway et al., 2011). Research into LsrB inhibitors, such as AI-2 analogs and small-molecule antagonists, seeks to deafen pathogens and attenuate their ability to cause disease (Ryu et al., 2016).

Other names
LuxS-regulated protein BAI-2-binding proteinAutoinducer-2-binding proteinPeriplasmic autoinducer-2 receptor
02

Mechanism of action

Competitive inhibition of autoinducer-2 (AI-2) binding to the periplasmic receptor, preventing the internalization of the signaling molecule and subsequent activation of quorum sensing-regulated virulence genes (Ryu et al., 2016).

03

Biological functions

Quorum sensingSignal transductionBacterial communicationActive transportLigand binding
04

Disease associations

Bacterial infectionBiofilm-associated infectionsGastrointestinal infectionSepsis
05

Safety considerations

Potential disruption of beneficial commensal microbiota quorum sensingSpecies-specific binding variations (e.g., borated vs. non-borated AI-2 forms)Potential for compensatory signaling pathways in complex microbial communities
06

Interacting drugs

(S)-4,5-dihydroxy-2,3-pentanedione (DPD) analogs

3 more in the full profile.

07

Biomarkers

Extracellular autoinducer-2 (AI-2) concentrationlsr operon expression levelsBiofilm formation indexPhospho-AI-2 (P-AI-2) intracellular levels

Beyond the preview

Go deeper on Autoinducer-2-binding periplasmic protein LsrB (LsrB) (LsrB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autoinducer-2-binding periplasmic protein LsrB (LsrB) (LsrB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call